| Literature DB >> 30344695 |
Lina Wu1, Wei Zhang1, Siyu Jia1, Xinyan Zhao1, Donghu Zhou1, Anjian Xu1, Weijia Duan1, Zhen Wu1, Hai Li2, Sujun Zheng3, Yuemin Nan4, Jidong Jia1, Jian Huang1, Xiaojuan Ou1.
Abstract
Dubin-Johnson syndrome (DJS) is a rare, autosomal recessive disorder characterized by predominantly conjugated hyperbilirubinemia, caused by a mutation in the adenosine triphosphate-binding cassette subfamily C member 2 (ABCC2) gene coding the multidrug resistance-associated protein 2 (MRP2) protein. ABCC2 mutations have been identified in patients with DJS worldwide; however, the mutation pattern of ABCC2 in China is not well studied. In the present study, the mutation pattern of the ABCC2 gene in Chinese patients with DJS was investigated. A total of 7 clinically confirmed patients with DJS were enrolled, and mutation analysis of the ABCC2 gene was performed by Sanger sequencing of genomic DNA extracted from whole blood. All 32 exons and the adjacent splice junction areas were sequenced. All cases were identified to harbor at least one non-synonymous variant in the ABCC2 gene, including three known mutations in 3 cases and three novel variants (p.G693R, p.G808V and p.E647X) in the other 4 cases, with the known p.R393W and the novel p.G693R and p.E647X variants identified in 2 of the 7 cases (28.6%), respectively. All the identified mutations were heterozygous, and 1 case presented with a compound heterozygous mutation, namely p.G693R/p.G808V, while the other cases carried only one single mutation. The loss of membrane expression of MRP2 caused by the novel nonsense variant, p.E647X, was confirmed by immunohistochemical analysis of liver biopsy. The present study provided the first report on the mutation patterns of the ABCC2 gene in Chinese patients with DJS, and the clinical association of these mutations with the syndrome.Entities:
Keywords: Dubin-Johnson syndrome; adenosine triphosphate-binding cassette subfamily C member 2; multidrug resistance-associated protein 2; mutation
Year: 2018 PMID: 30344695 PMCID: PMC6176208 DOI: 10.3892/etm.2018.6682
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447